European Commission proposes SPC waiver to boost generics

29-05-2018

European Commission proposes SPC waiver to boost generics

tdrbouz / iStockphoto.com

The European Commission has proposed a change in IP rules to allow pharmaceutical companies to produce generic drugs for export to non-EU countries that don’t have patent protection.


European Commission, supplementary protection certificates, SPCs, patent protection, export manufacturing waiver, biosimilar, generics


LSIPR